Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Janssen BioPharma presents new influenza endonuclease inhibitors

Oct. 19, 2021

Universidade do Minho discloses new antimalarials

Oct. 19, 2021

Integrin activator 7HP-349 shows efficacy as vaccine adjuvant in model of Chagas disease

Oct. 19, 2021

TechnoPhage identifies therapeutic antibody for COVID-19

Oct. 18, 2021

VX-01, a humanized antibody with protective effects against murine mucormycosis

Oct. 18, 2021

Roche discloses new compounds for E. coli infections

Oct. 18, 2021

NLS reports preclinical data on NLS-4 for long COVID

Oct. 15, 2021

Medshine Discovery discovers HBV cccDNA formation inhibitors

Oct. 15, 2021

Preclinical data support use of ibrexafungerp to treat mucormycosis

Oct. 13, 2021

NV-CoV-2 effective against SARS-CoV-2 in standard cell culture pseudovirion assay

Oct. 13, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...